Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)

Clinical trial NCT02938962 · UNKNOWN

Trial details

NCT number: NCT02938962
Sponsor: Mount Sinai Hospital, Canada
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Tranexamic Acid Blood Loss, Surgical Arthroplasty, Replacement, Hip

Start date: 2016-10-01
Primary completion: 2018-11-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.